Furthermore, we also observed that Juglone was able to induce Notch3 downmodulation and CHOP induction in vivo, finally exerting anti-leukemia growth in a human T-ALL xenograft mouse model. This evidence concerns the gene NOTCH3 and acute lymphoblastic leukemia.